EUVIMEDEUVIMED entdecken
Crossref

Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China

Siyu Zhang, Yuexin Huang, Danglun Luo

Economic Analysis and Policy · 2026-01 · 89 · 421-441

DOI: 10.1016/j.eap.2025.12.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Economic Analysis and Policy, 2026-01. Verfasst von Siyu Zhang und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Planning Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Planning Project

Zitieren

APA

Zhang, S., Huang, Y., & Luo, D. (2026). Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China. Economic Analysis and Policy, 89, 421-441. https://doi.org/10.1016/j.eap.2025.12.013

Vancouver

Zhang S, Huang Y, Luo D. Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China. Economic Analysis and Policy. 2026;89:421-441. doi:10.1016/j.eap.2025.12.013

BibTeX
@article{Zhang2026,
  author = {Zhang, Siyu and Huang, Yuexin and Luo, Danglun},
  title = {Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China},
  journal = {Economic Analysis and Policy},
  year = {2026},
  volume = {89},
  pages = {421--441},
  doi = {10.1016/j.eap.2025.12.013}
}
Kostenlos starten →